# loratadine D

NDC: 45802-122
Generic name: loratadine, Pseudoephedrine sulfate
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20180410

FDA application: ANDA076050

## Active ingredients

- LORATADINE: 5 mg/1
- PSEUDOEPHEDRINE SULFATE: 120 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-122"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-122
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01e61c73-3b81-4683-b1a9-8784c0d565b1